Survival RateGraft SurvivalCell SurvivalSurvival AnalysisDisease-Free SurvivalKaplan-Meier EstimateTreatment OutcomePrognosisRetrospective StudiesSurvivalLiver TransplantationKidney TransplantationTime FactorsProportional Hazards ModelsGraft RejectionFollow-Up StudiesNeoplasm StagingTissue DonorsTumor Markers, BiologicalKidney Failure, ChronicImmunohistochemistryMultivariate AnalysisPancreas TransplantationLiver FailureImmunosuppressive AgentsCadaverLiving DonorsRisk FactorsGene Expression Regulation, NeoplasticAdenocarcinomaBrain NeoplasmsLung NeoplasmsPostoperative ComplicationsCell Line, TumorBreast NeoplasmsLiver NeoplasmsDisease ProgressionProspective StudiesNeoplasm Recurrence, LocalGlioblastomaCohort StudiesNeoplasm MetastasisPeritoneal DialysisRenal DialysisNeoplasm InvasivenessTissue and Organ ProcurementCombined Modality TherapyReoperationTacrolimusApoptosisAntineoplastic Combined Chemotherapy ProtocolsPeritoneal Dialysis, Continuous AmbulatoryTissue Array AnalysisCarcinoma, HepatocellularWaiting ListsColorectal NeoplasmsRegistriesPredictive Value of TestsLymphatic MetastasisActuarial AnalysisAge FactorsMelanomaRecurrenceGene Expression ProfilingRisk AssessmentAntineoplastic AgentsImmunosuppressionTransplantation, HomologousOvarian NeoplasmsSignal TransductionDonor SelectionNeoplasmsCarcinoma, Non-Small-Cell LungDelayed Graft FunctionCarcinoma, Squamous CellGliomaCell ProliferationLife TablesStomach NeoplasmsCarcinomaPancreatic NeoplasmsReverse Transcriptase Polymerase Chain ReactionMycophenolic AcidBile Duct NeoplasmsIncidenceCause of DeathChemotherapy, AdjuvantCreatinineCholangiocarcinomaKidney NeoplasmsNeoplasm ProteinsCyclosporineHepatectomyChi-Square DistributionRNA, MessengerImmunoenzyme TechniquesCarcinoma, Renal CellPatient SelectionRenal Replacement TherapyCisplatin